Clinical trials: Cancer Care Providers
Papillomavirus Vaccines
Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination
Each year the human papillomavirus (HPV) causes 30,000 cancers in the United States despite the availability of very effective and safe vaccines.
- Trial name
- NCT03501992
- Testing
- Current care, Reminder-recall, Audit-and-feedback
- Where
- United States
- Volunteers
- 9,242 people
- Sponsor
- Mayo Clinic
Papillomavirus Vaccines
Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors
The focus of this research is on increasing the uptake of the human papillomavirus (HPV) vaccine in young cancer survivors, a vulnerable population at high risk for developing new cancers (such as cervical and anal cancer) caused…
- Trial name
- NCT04469569
- Testing
- HPV-PROTECT
- Where
- 6 sites in United States
- Volunteers
- 8,120 people
- Sponsor
- University of Alabama at Birmingham
Malignant Neoplasm, Surgical Procedure, Unspecified
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
This trial studies how well the use of a pre-surgical toolkit (OPTI-Surg) works in improving surgical care and outcomes in older participants with cancer.
- Conditions
- Malignant Neoplasm, Surgical Procedure, Unspecified, Health Care Provider, Carcinoma
- Trial name
- NCT03857620
- Testing
- Best Practice, Informational Intervention, Questionnaire Administration
- Where
- 44 sites in United States
- Volunteers
- 325 people
- Sponsor
- Alliance for Clinical Trials in Oncology